Exosome Signatures in Cardiac Sarcoidosis Disease Activity
Part of Blood & lymphatic, Immune system & allergy clinical trials.
This study looks for disease markers in tiny particles called exosomes in your blood to better understand cardiac sarcoidosis (a condition where inflammation affects the heart). By measuring these markers alongside your standard heart imaging, researchers hope to find better ways to detect and monitor the disease.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 18 years or older
- You have cardiac sarcoidosis (confirmed diagnosis) or your doctor suspects you may have it
- You are already scheduled for or undergoing FDG-PET imaging (a type of heart scan) as part of your regular care
- You are able to understand and provide informed consent to participate
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study collects and analyzes tissue or blood samples to better understand heart sarcoidosis and related inflammatory heart conditions. It may help doctors confirm diagnoses and improve care, especially in people with rhythm problems or results on heart scans.
This study checks whether a blood “cell-free DNA” test can show when the heart is inflamed in people with cardiac sarcoidosis. It may help doctors detect active heart involvement earlier and track how disease is doing.
This study tests how doctors can best tell whether someone has cardiac sarcoidosis, a condition where inflammation affects the heart. It may help you get a more accurate diagnosis using expert guidelines and special heart tests, and it groups patients as proven, probable, or unlikely.
This study follows people with sarcoidosis that may or may not be affecting the heart. It uses special scans (PET and MRI) to look for heart involvement and track how the disease changes over time.
This trial studies a treatment approach for people with active cardiac sarcoidosis, confirmed by specific heart rhythm/heart function problems and a PET scan. It may help by targeting the active inflammation driving heart conduction problems, rhythm events, or weak heart pumping.
This study checks whether a special heart scan called PET/MRI can predict how sarcoidosis may affect your heart. It may help doctors better estimate heart risk and plan follow-up based on scan findings.
Hear when a new Cardiac Sarcoidosis trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.